Literature DB >> 29080944

Comment on: "Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study)".

Arnaud Uguen1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29080944     DOI： 10.1007/s11523-017-0533-2

Source DB:  PubMed          Journal:  Target Oncol        ISSN： 1776-2596            Impact factor:   4.493


× No keyword cloud information.
  8 in total

1.  ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.

Authors:  Antonio Marchetti; Alessia Di Lorito; Maria Vittoria Pace; Manuela Iezzi; Lara Felicioni; Tommaso D'Antuono; Giampaolo Filice; Luigi Guetti; Felice Mucilli; Fiamma Buttitta
Journal:  J Thorac Oncol       Date:  2016-02-22       Impact factor: 15.609

2.  Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.

Authors:  A J van der Wekken; R Pelgrim; N 't Hart; N Werner; M F Mastik; L Hendriks; E H F M van der Heijden; M Looijen-Salamon; A J de Langen; J Staal-van den Brekel; S Riemersma; B E van den Borne; E J M Speel; A-M C Dingemans; T J N Hiltermann; A van den Berg; W Timens; E Schuuring; H J M Groen
Journal:  Clin Cancer Res       Date:  2017-02-09       Impact factor: 12.531

3.  Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.

Authors:  M I Ilie; C Bence; V Hofman; E Long-Mira; C Butori; L Bouhlel; S Lalvée; J Mouroux; M Poudenx; J Otto; C H Marquette; P Hofman
Journal:  Ann Oncol       Date:  2014-10-24       Impact factor: 32.976

4.  French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.

Authors:  Sylvie Lantuejoul; Isabelle Rouquette; Hélène Blons; Nolwenn Le Stang; Marius Ilie; Hugues Begueret; Valerie Grégoire; Paul Hofman; Audrey Gros; Stephane Garcia; Nathalie Monhoven; Mojgan Devouassoux-Shisheboran; Audrey Mansuet-Lupo; Françoise Thivolet; Martine Antoine; Jean-Michel Vignaud; Frederique Penault-Llorca; Françoise Galateau-Sallé; Anne McLeer-Florin
Journal:  Eur Respir J       Date:  2015-04-30       Impact factor: 16.671

5.  ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues.

Authors:  Arnaud Uguen; Sophie Andrieu-Key; Florence Vergne; Renaud Descourt; Gilles Quéré; Isabelle Quintin-Roué; Stéphane Key; Paul Guéguen; Matthieu Talagas; Marc De Braekeleer; Pascale Marcorelles
Journal:  Oncol Rep       Date:  2016-07-21       Impact factor: 3.906

6.  Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances.

Authors:  Florian Cabillic; Audrey Gros; Frédéric Dugay; Hugues Begueret; Laura Mesturoux; Dan Cristian Chiforeanu; Leila Dufrenot; Vincent Jauffret; Dominique Dachary; Romain Corre; Alexandra Lespagnol; Gwendoline Soler; Julien Dagher; Véronique Catros; Michèle Le Calve; Jean-Philippe Merlio; Marc-Antoine Belaud-Rotureau
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

7.  Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study).

Authors:  Jean-Bernard Auliac; Isabelle Monnet; Catherine Dubos-Arvis; Anne Marie Chiappa; Nathalie Baize; Suzana Bota; Alain Vergnenegre; Helene Doubre; Chrystele Locher; Acya Bizieux; Gilles Robinet; Christos Chouaid
Journal:  Target Oncol       Date:  2017-12       Impact factor: 4.493

8.  Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?

Authors:  Ibiayi Dagogo-Jack; Alice T Shaw
Journal:  Oncologist       Date:  2016-05-31
  8 in total
  1 in total

1.  Author's Reply to Arnaud Uguen: "Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02-14 Study)".

Authors:  Jean-Bernard Auliac; Christos Chouaid
Journal:  Target Oncol       Date:  2017-12       Impact factor: 4.493
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.